Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Immunological Methods|April 28, 2024
PD-BAT: A novel approach of pooling basophil donors for expansion of commercial laboratory testing of Chronic Spontaneous UrticariaSaintedym Wills, Jessica Chavez, Ajay Grover, et al.
Immunology|May 15, 2017
Humanized NOG mice as a model for tuberculosis vaccine-induced immunity: a comparative analysis with the mouse and guinea pig models of tuberculosisAjay Grover, Amber Troy, Jenny Rowe, et al.
Journal of Immunological Methods|December 6, 2025
Automation and performance validation of the pooled donor basophil activation test for chronic urticaria using the Hamilton STAR systemJessica Chavez, Evan W McConnell, Rogger Alcalde, et al.
Vaccine|May 1, 2016
Heat killed Saccharomyces cerevisiae as an adjuvant for the induction of vaccine-mediated immunity against infection with Mycobacterium tuberculosisAjay Grover, Jennifer L McLean, JoLynn M Troudt, et al.
Clinical Immunology (Orlando, Fla.)|September 4, 2007
Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous miceMamta Kalra, Ajay Grover, Neena Mehta, et al.
Infection and Immunity|December 8, 2010
Three protein cocktails mediate delayed-type hypersensitivity responses indistinguishable from that elicited by purified protein derivative in the guinea pig model of Mycobacterium tuberculosis infectionHongliang Yang, JoLynn Troudt, Ajay Grover, et al.
Tuberculosis (Edinburgh, Scotland)|October 4, 2011
Assessment of vaccine testing at three laboratories using the guinea pig model of tuberculosisAjay Grover, Jolynn Troudt, Kimberly Arnett, et al.
Immunology and Cell Biology|July 18, 2012
HspX-mediated protection against tuberculosis depends on its chaperoning of a mycobacterial moleculeJennifer L Taylor, Agatha Wieczorek, Andrew R Keyser, et al.
MMWR. Morbidity and Mortality Weekly Report|November 27, 2024
Detection of Increased Activity of Human Parvovirus B19 Using Commercial Laboratory Testing of Clinical Samples and Source Plasma Donor Pools - United States, 2024David Alfego, Alfonso C Hernandez-Romieu, Melissa Briggs-Hagen, et al.
Vaccine|June 9, 2009
Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosisRonggai Sun, Yasir A W Skeiky, Angelo Izzo, et al.
Pageof 2